Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
51.83Price to Sales
VS
Market
Sector
Industry
History
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information
Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADVERUM BIOTECHNOLOGIES INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADVM - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 51.83M | 51.83 | $ 1M |
| 3/31/2025 | $ 43.03M | 43.03 | $ 1M |
| 12/31/2024 | $ 67.48M | 67.48 | $ 1M |
| 9/30/2024 | $ 156.85M | 156.85 | $ 1M |
| 6/30/2024 | $ 135M | 0 | $ 0 |
| 3/31/2024 | $ 199.47M | 0 | $ 0 |
| 12/31/2023 | $ 367.36M | 102.04 | $ 3.6M |
| 9/30/2023 | $ 91.93M | 25.54 | $ 3.6M |
| 6/30/2023 | $ 184.82M | 51.34 | $ 3.6M |
| 3/31/2023 | $ 84.48M | 23.47 | $ 3.6M |
Key Performance Insights, Last 5 Years
- ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average P/S has been 54.12.
- The median P/S for ADVERUM BIOTECHNOLOGIES INC during this period was 45.61
- ADVERUM BIOTECHNOLOGIES INC reached its highest P/S over the past 5 years at 156.85.
- The lowest P/S recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe 18.3
ADVERUM BIOTECHNOLOGIES INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Market Cap [ $ 1.19B ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] ADVM - Price to Sales, Last 5 years
18.3
Minimum
Dec 31, 2021
156.85
Maximum
Sep 30, 2024
54.12
Average
45.61
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |